Elysium Health

Elysium Health offers health products that are built with science. Elysium’s mission is to solve the biggest challenges in health with science, to help people live healthier, longer lives. The company works directly with the world’s best scientists, clinicians and health professionals to identify and develop the most innovative and promising natural compounds. Elysium Health's product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.
Company Growth (employees)
New York, US
Size (employees)
29 (est)+12%
Elysium Health was founded in 2014 and is headquartered in New York, US

Elysium Health Office Locations

Elysium Health has an office in New York
New York, US (HQ)
707 594 Broadway

Elysium Health Data and Metrics

Summary Metrics

Founding Date


Total Funding

$28.2 m

Latest funding size

$22 m

Time since last funding

10 months


Elysium Health's latest funding round in December 2016 was reported to be $22 m. In total, Elysium Health has raised $28.2 m

Traffic Overview of Elysium Health

Elysium Health Online and Social Media Presence

Elysium Health News and Updates

Forever Young: 10 Anti-Aging Startups To Watch

By 2050, the US population aged 65 and older is projected to reach 83.7M, almost double its population in 2012. To combat the aging process and help people lead longer and healthier lives, pharmaceutical corporates and tech giants alike have … Continued

Unbundling CVS: 80+ Startups Attacking The Drug Store Shelves

The consumer packaged goods sector has historically been controlled by large multinationals such as Unilever, Procter & Gamble, Johnson & Johnson, etc. However, startups have been moving into the space, applying the same sort of technologies that have already transformed … Continued

A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

 Chromadex, the sole supplier of anti-aging startup Elysium Health‘s two main product ingredients pterostilbene and Nicotinamide Riboside (NR), is suing the startup for failure to make payments on those ingredients and for breach of a trademark and royalties agreement. According to a document on Chr…

A startup that's developed an anti-aging supplement just raised $20 million

A startup that's developing an anti-aging supplement just raised $20 million to keep studying it and other supplements.  Elysium Health, the brainchild of former Sequoia partner Eric Marcotulli, former JPMorgan vice president Dan Alminana, and MIT biology professor Leonard G…

Term Sheet — Tuesday, December 6

On deals and dealmakers.

Anti-aging pill startup Elysium Health inks at least $20 million in Series B funding

 Elysium Health markets a pill formulated with ingredients it says will keep you feeling young and, according to a source close to the matter and documents obtained by TechCrunch, the startup has closed on $20 million in Series B financing at what we’re told is a $157 million pre-money valuation fro…
Show more

Elysium Health Company Life and Culture

You may also be interested in